Teracilin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Teracilin

Quick Facts

Property Description
Active ingredient Tetracycline hydrochloride
Form Oral capsules, tablets, topical preparations
Pharmacological class Tetracycline antibiotic
Common use Anti-infective therapy
Origin Semi-synthetic

What Type of Medicine Is Teracilin (Tetracycline)?

Teracilin is a prescription-only medication whose active substance is Tetracycline hydrochloride, and it belongs to the Tetracycline group of antibiotics, a class recognized for its utility in infectious disease management. The medication is defined as a broad-spectrum agent, meaning it is designed to combat a wide variety of bacterial infections. It functions as a core component of anti-infective therapy, aiming to control harmful bacterial populations.

Composition and Origin: How Tetracycline Works

The therapeutic action of Teracilin is provided by the active ingredient, Tetracycline hydrochloride, which is classified as a semi-synthetic compound. This substance operates as a bacteriostatic agent, meaning its primary mechanism is to inhibit the growth and reproduction of bacteria rather than directly destroying them. This inhibition occurs because Tetracycline selectively interferes with the bacteria’s vital protein synthesis process. This process involves binding to the bacterial 30S ribosomal subunit, which hinders protein production and growth. This specific action stops the infection from progressing, allowing the body's natural defenses to clear the weakened pathogens.

Available Forms of Tetracycline

Tetracycline is formulated as a single active ingredient product and is available in forms tailored for different routes of administration, distinguishing its application based on the infection site. Common preparations include oral capsules and tablets for systemic treatment, as well as topical preparations (such as ointments) and dedicated ophthalmic preparations for localized use. This variety ensures the Tetracycline hydrochloride can be delivered effectively, whether treating a systemic infection or a localized one.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Teracilin?

Possible Side Effects and Safety Information

The official safety profile for Teracilin (Tetracycline hydrochloride) is based on regulatory classifications of adverse reactions across major physiological systems. These effects are formally grouped by frequency and type as documented by government health authorities.


Documented Adverse Reaction Categories

Classification Examples of Officially Listed Reactions
Common Gastrointestinal disturbances, including nausea, vomiting, and diarrhea. Esophagitis and related irritation are also documented.
Uncommon/Rare Severe hypersensitivity reactions (e.g., anaphylaxis), benign intracranial hypertension (pseudotumor cerebri), and severe hepatotoxicity.

System-Organ Classes and Serious Risks

Adverse effects are documented across the Gastrointestinal, Dermatological, Nervous System, and Hepatobiliary Disorders. Clinically significant reactions that are explicitly listed in regulatory documents include Benign Intracranial Hypertension, a condition involving increased pressure around the brain, and Clostridium difficile-associated Diarrhea (CDAD). These are listed alongside serious allergic responses like anaphylaxis.

Population-Specific Safety Constraints

The regulatory label outlines specific safety limitations for certain patient groups. The use of Teracilin is associated with the risk of permanent tooth discoloration (yellow-gray-brown) and enamel hypoplasia in children under eight years of age and during the last half of pregnancy. Additionally, patients with renal impairment carry a documented risk of drug accumulation and potential for severe hepatotoxicity.

Safety Restrictions and Patterns

A mandatory restriction noted in official labeling is the risk of photosensitivity; patients must avoid excessive exposure to direct sunlight or ultraviolet light. Furthermore, time-related safety patterns indicate that gastrointestinal effects are often more prominent at the start of treatment, while prolonged use carries a risk of superinfection from non-susceptible organisms.

Overdose and Emergency Response

Overdose and When to Seek Help

If you suspect an overdose of Teracilin, seek emergency medical attention immediately. Contact a hospital emergency department or regional poison control center, even if you do not feel any symptoms.

Documented Overdose Risks and Symptoms

High doses of Teracilin (a Tetracycline-class drug) are associated with the risk of severe toxicity affecting major organ systems. The most critical risks documented in regulatory information include liver failure, which can be fatal, and other serious hepatic effects such as fatty liver degeneration. Overdose can also lead to pancreatitis.

Patients with pre-existing impaired kidney function are at higher risk for systemic drug accumulation, which increases the potential for liver toxicity and other adverse effects, even when taking standard doses.

Emergency Actions and Response

In the event of an overdose, the medication should be discontinued immediately, and medical professionals will initiate supportive measures. Overdoses of Teracilin are not effectively treated by hemodialysis.

Additionally, the use of Teracilin past its expiration date is explicitly linked to the development of a reversible form of kidney damage known as renal tubular acidosis (Pseudo-Fanconi syndrome).

Therapeutic Uses of Teracilin

What Teracilin Treats: Main Uses and Benefits

Teracilin (a medication) is generally applied across domains where short-term symptomatic assistance is needed to manage conditions presenting with systemic or localized discomfort and contributes to easing the overall symptom load. The medication is commonly used across conditions presenting with acute episodes. This therapeutic approach is relevant when supportive symptom management is appropriate and symptoms become temporarily overwhelming.

Teracilin is used in clinical settings that involve acute or unstable symptom patterns associated with certain respiratory, urinary, and intestinal conditions. It is also applied in addressing specific skin and soft tissue manifestations, such as severe acne (adjunctive therapy), and for managing discomfort in specialized atypical illnesses like certain tick-borne diseases.

“It helps address symptom clusters that may appear suddenly, providing support that assists with maintaining functional stability during phases of increased distress.”


Quick Fact: Support for Inflammatory Symptoms

Teracilin is relevant for managing symptoms that interfere with daily comfort in conditions involving inflammatory or irritative states, which supports general well-being during symptomatic phases.

Regulatory References

  1. NIH DailyMed drug label for Tetracycline Hydrochloride

Eligibility and Restrictions for Use

Eligibility and Contraindications for Teracilin Use

Teracilin (Tetracycline) is a prescription medicine whose use is strictly governed by regulatory eligibility criteria defined in official governmental labeling. These rules define which populations are permitted to use the medicine, and which populations are prohibited due to documented safety concerns.

Population Status Eligibility Rule
Contraindicated Use is prohibited for individuals with a known hypersensitivity to any drug in the tetracycline class [Source 2.1].
Contraindicated during the last half of pregnancy and in nursing mothers [Source 2.6, 3.1].
Contraindicated in patients with severe renal impairment or severe liver impairment [Source 2.4, 3.1].
Not Recommended Use is generally not recommended in children under 8 years of age due to the risk of permanent tooth discoloration and enamel hypoplasia [Source 2.6].
Conditional Use Patients with non-severe impaired renal function require caution and potential dosage adjustment [Source 1.3].
Older adults require caution due to the possibility of subclinical renal insufficiency [Source 2.3].
Prohibited Concomitant Use Must not be used concurrently with systemic retinoids such as isotretinoin due to the increased risk of intracranial hypertension [Source 2.6].

Eligibility for adults is established, while use in children 8 years of age and older is approved when alternative treatments are ineffective.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Teracilin (Tetracycline hydrochloride) identifies several mandatory restrictions and constraints based on established interaction outcomes.

Contraindicated Combinations Co-administration is strictly prohibited with retinoids (such as tretinoin and acitretin) because both substance classes are associated with Intracranial Hypertension. The drug is also contraindicated with methoxyflurane due to documented reports of fatal renal toxicity.

Absorption-Limiting Interactions Teracilin's oral absorption is severely reduced by multivalent cations through chelation, leading to lower systemic drug exposure. This includes antacids containing aluminum, calcium, or magnesium, and preparations containing iron or zinc salts. Mandatory timing rules require separation: Teracilin must be taken two hours before or six hours after ingesting these cation-containing products or dairy products.

Pharmacodynamic Interactions When taken with anticoagulant therapy (e.g., warfarin), Teracilin may depress plasma prothrombin activity, necessitating a downward adjustment of the anticoagulant dosage. Concomitant use with penicillin-class antibiotics should be avoided due to the potential for pharmacodynamic antagonism. Teracilin may also render oral contraceptives less effective. Patients with renal dysfunction face an increased risk of accumulation, which can heighten the anti-anabolic effect, potentially causing an officially documented increase in Blood Urea Nitrogen (BUN).

Mechanism of Action

Targeted Inhibition of Bacterial Protein Synthesis

Teracilin (Tetracycline) exerts its action by specifically and reversibly binding to the bacterial 30S ribosomal subunit. This molecular interaction causes a steric blockade at the Acceptor (A) site, effectively preventing aminoacyl-transfer RNA from delivering new amino acids. This mechanism directly interrupts the translation process, arresting the synthesis of proteins required for bacterial growth and division.


Achieving Bacteriostasis and Pathogen Control

The cellular consequence of inhibiting protein synthesis is bacteriostasis—the physiological state where the pathogen population is unable to multiply exponentially. By stopping cellular proliferation, the mechanism causes a significant suppression of the pathogen population. This physiological adjustment reduces the infectious load, allowing the host's immune system time to clear the non-multiplying pathogens.


Limitations from Bacterial Resistance Pathways

The effectiveness of the mechanism is constrained by specific bacterial defenses, notably efflux pumps and ribosomal protection proteins. Efflux pumps actively transport the drug out of the cell, preventing it from reaching the necessary inhibitory concentration at the 30S subunit target. When these mechanisms are present, the primary blockade of protein synthesis is overcome, allowing the bacterial population to resume growth.

Dosage and Administration Information

Teracilin, a tetracycline-class antibiotic, is typically taken by mouth as a capsule or tablet and is generally prescribed in multiple daily doses. Following the precise dosing and duration instructions provided by your healthcare provider is critical for treatment effectiveness and minimizing the risk of developing drug-resistant bacteria.

Administration Guidelines

Guideline Instruction
Timing with Food Take Teracilin on an empty stomach, at least one hour before or two hours after meals or snacks. This is because food, especially dairy products like milk and cheese, can significantly reduce the drug's absorption.
Swallowing Swallow the capsule or tablet whole with a full glass of water (8 ounces/240 milliliters). This helps to prevent irritation of the esophagus, which is a rare but reported risk with tetracycline-class drugs. Avoid lying down for at least 10 minutes after taking a dose.
Missed Doses Take a missed dose as soon as you remember, unless it is almost time for your next scheduled dose. If so, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one.
Course Completion Continue taking the medication for the full prescribed length of time, even if your symptoms improve quickly. Stopping treatment too soon may allow the infection to return.

Interactions with Other Products

Teracilin's absorption can be impaired by products containing multivalent cations such as aluminum, calcium, iron, magnesium, and zinc. This includes many antacids, mineral supplements, and vitamin products. To avoid this interaction, administer Teracilin two to three hours before or after taking any of these products. Always consult your healthcare professional about all other medications and supplements you are currently taking.

Recent Clinical Evidence

Research evidence / Overview of Studies for Teracilin

Evidence for Use in Acute Systemic Infections

Research for this medicine includes Randomized Controlled Trials (RCTs) and studies conducted to meet regulatory requirements. These studies focused on adult participants and monitored outcomes related to systemic or functional imbalance, such as measured clinical endpoints and observations related to microbiological measurements (pathogen reduction). Studies reported measurements of the proportion of participants who experienced symptom evolution during the defined treatment time interval. While the evidence contributes to understanding symptom patterns for core infectious uses, evidence is limited regarding observations against all currently circulating strains, given the evolution of antimicrobial resistance (AMR).

Evidence for Use in Severe Acne

Controlled clinical trials have explored whether this medicine had a role in adolescents and adults with moderate to severe acne. The primary goal of this research was to measure outcomes linked to changes in inflammatory or irritative states, specifically the count of skin lesions. Research highlights changes measured during the study period (typically over several months), with findings describing patterns of change in the measured inflammatory component. The durability of these findings is an area where long-term effects are not fully established. The optimal time for patients to use this medicine for maintenance is an area that requires further exploration.

The Landscape of Long-Term Evidence and Follow-up

Regulatory data collection often involves an extended observation of participants following initial treatment. Research provides insight into short-term changes, but the data beyond the duration of the initial intervention primarily comes from these extended observation periods. Long-term effects are not fully established regarding sustained effects after treatment concludes or use for durations exceeding those examined in primary clinical trials. Follow-up durations were limited in many of the primary efficacy trials, meaning that there is limited information for long-term outcomes.

Evidence in Special Patient Populations

The majority of the foundational research was evaluated in adult patient populations. Specific studies have examined the use of the medicine in populations where symptoms may vary in intensity, such as individuals with certain coinfections. Data for certain groups remain insufficient. Specific studies focusing on older adults are often limited, and the evidence regarding safety and efficacy during pregnancy is not fully established.

Key Studies & References

  1. Tetracycline Hydrochloride Capsules, USP: DailyMed Drug Label

Frequently Asked Questions (FAQ)

Common questions about Teracilin (FAQ)

Q: What are the main conditions that Teracilin is used to treat?

A: According to official regulatory documents, Teracilin is approved for the treatment of a variety of bacterial infections. This includes specific upper and lower respiratory tract infections, Rickettsial diseases, and certain Chlamydia infections. It is also used as an adjunctive treatment, meaning a supportive treatment, for severe acne.

Q: How quickly does Teracilin start working?

A: Teracilin is a bacteriostatic medicine, which means its primary mechanism is to stop the growth and reproduction of bacteria. For effective treatment, official guidelines describe the necessity of completing the full prescribed course of treatment, regardless of the perceived speed of initial changes.

Q: How long after starting Teracilin should I expect to see results?

A: The medicine works by suppressing the bacteria population and reducing the infectious load. Due to its mechanism, official guidelines describe the necessity of continuing treatment for the full prescribed length of time. Stopping treatment prematurely has been associated with the potential for the infection to return, even if signs of improvement appear quickly.

Q: Is Teracilin known by any other names?

A: The active ingredient in Teracilin is Tetracycline hydrochloride. This ingredient is the internationally recognized generic name for the medicine. Historically, this active substance has been marketed under various brand names, in addition to being widely available as a generic medicine.

Q: Does Teracilin cure the condition or just manage the symptoms?

A: Teracilin is officially classified as a bacteriostatic agent. This means its main function is to inhibit, or stop, the growth and multiplication of the bacteria. This action reduces the overall infectious load, allowing the body's own immune system to clear the remaining non-multiplying pathogens.

Q: Is Teracilin considered a long-term or short-term treatment?

A: For acute bacterial infections, Teracilin is typically used for short courses of treatment. However, for certain approved conditions that require extended management, such as severe acne, it may be used as part of a regimen that lasts for several months.

Q: Are the side effects of Teracilin usually serious?

A: The official safety profile groups adverse effects into different categories based on frequency. The most frequently reported effects are generally categorized as Common, such as mild gastrointestinal issues. Serious but uncommon or rare effects, such as severe allergic reactions and benign intracranial hypertension, are also documented in regulatory reports.

Q: Do the side effects of Teracilin go away over time?

A: Official documentation notes that side effects related to the gastrointestinal system, such as nausea or diarrhea, are often more prominent at the start of treatment. The duration and resolution of other documented adverse effects may depend on the specific type of reaction.

Q: How is Teracilin eliminated from the body?

A: Once the medicine has been absorbed and used by the body, Teracilin is primarily concentrated by the liver in the bile. It is then eliminated from the body through excretion in both the urine and the feces.

Q: Can alcohol be consumed while taking Teracilin?

A: Official prescribing information does not contain a specific mandatory warning or prohibition regarding moderate alcohol consumption. Any decision on whether to consume alcohol is left to the individual and their healthcare provider.

Q: How long has Teracilin been approved for use?

A: The family of antibiotics to which Teracilin belongs, known as Tetracyclines, has a long history. This class of medicine was discovered and first approved for therapeutic use around 1948.

Q: What does the term 'Teracilin' mean or where does the name come from?

A: The name for the class of medicine, Tetracycline, refers to its specific chemical structure. This structure is defined by a characteristic system of four hydrocarbon rings, which is where the prefix 'tetra' (meaning four) comes from.

Q: Is Teracilin addictive or habit-forming?

A: Official regulatory documents for Teracilin do not list it as a substance with known addictive properties or potential for abuse. The medicine is not classified as a controlled substance in the context of dependence risk.

Q: Is there a generic version of Teracilin available?

A: The active ingredient in Teracilin is Tetracycline hydrochloride, which is the internationally recognized generic name. This ingredient is widely available as a generic medicine and may be supplied by various manufacturers.

Q: Is it possible to develop a tolerance to Teracilin over time?

A: From a microbiology perspective, the core regulatory concern relates to the development of antibiotic resistance in bacterial populations. Official documents describe mechanisms, such as efflux pumps, that allow bacteria to actively remove the medicine from their cells, which can reduce its effectiveness over time.

Q: Are there specific tests required before starting Teracilin?

A: Official guidelines describe the standard procedure of susceptibility testing prior to use for many infections. This laboratory test helps ensure that the bacteria causing the infection are responsive to Teracilin, which is critical for selecting the appropriate anti-infective therapy.

Q: Does Teracilin require a special prescription or monitoring?

A: Teracilin is a prescription-only medicine. Regulatory documentation notes that for patients using the medicine over a long period of time, such as for specific skin conditions, periodic monitoring of kidney and liver function via blood tests may be necessary.

Q: What is a 'contraindication' as it relates to Teracilin?

A: The term contraindication means that a specific condition or circumstance makes the use of Teracilin inappropriate or potentially harmful. Official documents prohibit the use of Teracilin when a contraindication is present, such as a known severe allergy or existing severe organ impairment.

How should Teracilin be stored and disposed of?

Storage Requirements

Teracilin (Tetracycline Hydrochloride) must be stored at Controlled Room Temperature, specifically between 20°C and 25°C (68°F and 77°F), as required by official labeling. The medicine must be kept in its original container and the container must remain tightly closed to prevent moisture exposure. It is mandatory to protect the capsules from strong sunlight and excessive heat, as improper storage can cause the product to darken and lose potency. All medications must be stored out of the sight and reach of children.


Disposal Instructions

For disposal of unused or expired Teracilin, utilize a drug take-back program if one is available in your community. If no take-back program exists and the labeling provides no specific instructions, the medicine should be mixed with an undesirable substance (such as dirt or used coffee grounds) and sealed in a bag before being placed in the household trash. Do not flush this medicine down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Teracilin found in:

A-Z Index: